These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2492102)

  • 21. Interleukin 2 pseudomonas exotoxin (IL2-PE66(4)Glu) chimeric protein kills B cells from patients with Myasthenia gravis.
    Steinberger I; Brenner T; Lorberboum-Galski H
    Cell Immunol; 1996 Apr; 169(1):55-61. PubMed ID: 8612294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts.
    Heimbrook DC; Stirdivant SM; Ahern JD; Balishin NL; Patrick DR; Edwards GM; Defeo-Jones D; FitzGerald DJ; Pastan I; Oliff A
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4697-701. PubMed ID: 2352944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
    Batra JK; Fitzgerald DJ; Chaudhary VK; Pastan I
    Mol Cell Biol; 1991 Apr; 11(4):2200-5. PubMed ID: 2005905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.
    FitzGerald DJ; Pastan I
    Biochem Soc Trans; 1992 Nov; 20(4):731-4. PubMed ID: 1487051
    [No Abstract]   [Full Text] [Related]  

  • 25. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.
    Kondo T; FitzGerald D; Chaudhary VK; Adhya S; Pastan I
    J Biol Chem; 1988 Jul; 263(19):9470-5. PubMed ID: 3132465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of dichotomous action of IL-2-Pseudomonas exotoxin 40 (IL-2-PE40) on cell-mediated and humoral immune response.
    Volk HD; Müller S; Yarkoni S; Diamantstein T; Lorberboum-Galski H
    J Immunol; 1994 Sep; 153(6):2497-505. PubMed ID: 8077661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.
    Fischer A; Wolf I; Fuchs H; Masilamani AP; Wolf P
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33260619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.
    Sokolova E; Proshkina G; Kutova O; Shilova O; Ryabova A; Schulga A; Stremovskiy O; Zdobnova T; Balalaeva I; Deyev S
    J Control Release; 2016 Jul; 233():48-56. PubMed ID: 27178808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
    Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
    Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin.
    Puri RK; FitzGerald D; Leland P; Kozak RW; Pastan I
    Cell Immunol; 1992 Sep; 143(2):324-34. PubMed ID: 1511480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High level expression, purification and cytotoxicity of IL-10(18-57)-PE40].
    Peng QS; Li YH; Zhu P
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):87-93. PubMed ID: 16572846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts.
    Friedman PN; Chace DF; Trail PA; Siegall CB
    J Immunol; 1993 Apr; 150(7):3054-61. PubMed ID: 8454873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs.
    Siegall CB; Liggitt D; Chace D; Mixan B; Sugai J; Davidson T; Steinitz M
    Clin Cancer Res; 1997 Mar; 3(3):339-45. PubMed ID: 9815690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-chain immunotoxin fusions between anti-Tac and Pseudomonas exotoxin: relative importance of the two toxin disulfide bonds.
    Kreitman RJ; Batra JK; Seetharam S; Chaudhary VK; FitzGerald DJ; Pastan I
    Bioconjug Chem; 1993; 4(2):112-20. PubMed ID: 7873642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mik-beta 1(Fv)-PE40, a recombinant immunotoxin cytotoxic toward cells bearing the beta-chain of the IL-2 receptor.
    Kreitman RJ; Schneider WP; Queen C; Tsudo M; Fitzgerald DJ; Waldmann TA; Pastan I
    J Immunol; 1992 Oct; 149(8):2810-5. PubMed ID: 1401913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxicity of recombinant Fab and Fv immunotoxins on adult T-cell leukemia lymph node and blood cells in the presence of soluble interleukin-2 receptor.
    Saito T; Kreitman RJ; Hanada S; Makino T; Utsunomiya A; Sumizawa T; Arima T; Chang CN; Hudson D; Pastan I
    Cancer Res; 1994 Feb; 54(4):1059-64. PubMed ID: 8313362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant anti-erbB2 immunotoxins containing Pseudomonas exotoxin.
    Batra JK; Kasprzyk PG; Bird RE; Pastan I; King CR
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5867-71. PubMed ID: 1352878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
    Wang QC; Pai LH; Debinski W; FitzGerald DJ; Pastan I
    Cancer Res; 1993 Oct; 53(19):4588-94. PubMed ID: 8402632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and expression of the gene coding for IL-2(60)-PE40, a molecular targeted protein.
    Zhang M; Zhao X; Li H; Lu S
    Chin Med Sci J; 1995 Sep; 10(3):136-40. PubMed ID: 8580481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [An experimental study of corneal allograft rejection with cytotoxin IL-2-PE40].
    Wu J; Zhou G
    Zhonghua Yan Ke Za Zhi; 1995 Sep; 31(5):370-3. PubMed ID: 8706588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.